CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Feb. 28, 2025	Feb. 29, 2024	Aug. 31, 2024	Aug. 31, 2023
Operating Activities
Net (loss) earnings	$ 42,624	$ 35,555
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent	0	(622)
Net Earnings from Continuing Operations	42,624	36,177
Impairment & divestiture (benefits) charges	0	147
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	6,985	6,754
Stock-based compensation expense	6,186	5,527
Benefit for deferred income taxes	3,089	418
Amortization of debt issuance costs	293	292
Other Noncash Income (Expense)	(15)	1,954
Changes in components of working capital and other, excluding acquisitions and divestitures:
Accounts receivable	(6,830)	(375)
Inventories	(9,426)	(7,818)
Trade accounts payable	(1,658)	(6,514)
Prepaid expenses and other assets	(5,224)	(5,806)
Income tax accounts	(5,297)	1,345
Accrued compensation and benefits	(6,170)	(12,625)
Other accrued liabilities	(8,449)	(7,411)
Cash provided by (used in) operating activities, Continuing Operations	16,108	12,065
Cash (used in) provided by operating activities, Discontinued Operations	0	(5,413)
Cash (Used in) Provided By Operating Activities	16,108	6,652
Investing Activities
Capital expenditures	(11,517)	(3,152)
Payments to Acquire Businesses, Net of Cash Acquired	27,196	0
Cash used in investing activities, Continuing Operations	(38,713)	(5,687)
Cash Provided by Investing Activities	(38,713)	(5,687)
Financing Activities
Borrowings on Revolving Credit	14,421	48,000
Principal Repayment on Revolving Credit Facility	(14,421)	(16,000)
Principal repayments on term loan	(2,500)	(1,250)
Taxes paid related to the net share settlement of equity awards	(7,401)	(3,076)
Stock option exercises & other	1,554	2,871
Cash dividend	(2,167)	(2,178)
Net Cash Used in Financing Activities, Continuing Operations	(25,069)	(1,741)
Cash used in financing activities	(25,069)	(1,741)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total	(47,585)	(722)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	89	54
Payments for Repurchase of Common Stock	(14,555)	(30,108)
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents	119,509	153,693	$ 167,094	$ 154,415
Purchase of assets	0	(1,402)
Working capital adjustment from the sale of business assets	$ 0	$ (1,133)